405 results on '"Budd, G. Thomas"'
Search Results
102. Primary Ewing’s sarcoma of the ethmoid sinus with intracranial and orbital extension: Case report and literature review
103. HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma
104. S0221: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer.
105. Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
106. Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
107. Monitoring apoptosis and Bcl‐2 on circulating tumor cells in patients with metastatic breast cancer
108. Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
109. Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
110. Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy.
111. Docetaxel, carboplatin, trastuzumab, and bevacizumab (TCH+B) for early-stage HER2/neu(+) breast cancer and bone marrow micrometastases.
112. Use of HER2 score correction for putative chromosome 17 (Chr-17) aneusomy to increase eligibility for anti-HER2 therapy.
113. Abstract 2372: Capture and molecular characterization of CTC in metastatic breast, prostate, colorectal, and renal cancer
114. Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
115. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer
116. Male Breast Carcinoma Metastatic to the Choroid: Report of 3 Cases and Review of the Literature
117. S9511
118. The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence
119. Sorting through the recent controversies in breast cancer screening
120. A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
121. Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status
122. Let Me Do More Than Count the Ways: What Circulating Tumor Cells Can Tell Us about the Biology of Cancer
123. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
124. Cardiac Screening for Late-Onset Cardiomyopathy in Recipients of Cardiotoxic Chemotherapy: Pilot Data from a Prospective Study
125. Incidence of Advanced Symptomatic Disease as Primary Endpoint in Screening and Prevention Trials
126. Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients
127. Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
128. Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR
129. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
130. HER-2 Amplification in Tubular Carcinoma of the Breast
131. The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: A fluorescence in situ hybridization study
132. Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator
133. Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies
134. Phase 1 Trial of Subcutaneous IL-6 in Patients With Refractory Cancer: Clinical and Biologic Effects
135. Mature Results From a Phase II Trial of Accelerated Induction Chemoradiotherapy and Surgery for Poor Prognosis Stage III Non-Small-Cell Lung Cancer
136. Hypercalcemia Caused by Metastatic Adamantinoma: Response to Radiotherapy
137. Phase II Trial of Interleukin-2 and Interferon-ce in Patients with Renal Cell Carcinoma: Clinical Results and Immunologic Correlates of Response
138. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer
139. Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry.
140. A Southwest oncology group phase ii trial of recombinant tumor necrosis factor in metastatic breast cancer
141. Male breast carcinoma metastatic to the choroid: report of 3 cases and review of the literature.
142. The expression of TRMT2A, a novel cell cycleregulated protein, identifies a subset of breastcancer patients with HER2 over-expression thatare at an increased risk of recurrence.
143. Phase I Trial of Continuous Infusion Interleukin-2 and Doxorubicin in Patients with Refractory Malignancies
144. A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer
145. Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial
146. Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.
147. A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer.
148. Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast.
149. Cardioprotective Effect of -Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
150. Automated Quantitative RNA in SituHybridization for Resolution of Equivocal and Heterogeneous ERBB2(HER2) Status in Invasive Breast Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.